The plasma ACTH responses to hydrocortisone infusion were compared in patients with Cushing's disease and primary adrenocortical insufficiency. In 4 patients with primary adrenocortical insufficiency, plasma ACTH levels were suppressed exponentially after administration of a relatively large dose of hydrocortisone (1.0 mg/kg/1.5 hr-3.0mg/kg/2 hr). In patients with post-adrenalectomized Cushing's disease (4, bilateral; 1, unilateral), plasma ACTH suppression was delayed. Plasma ACTH levels, expressed as a percentage of the basal concentrations, were significantly less suppressed in patients with Cushing's disease than in patients with primary adrenocortical insufficiency 90 (p <0.05) and 120 (p <0.05) min after the beginning of infusion. When 0.5mg/kg hydrocortisone was infused over a period of 1.5 hr, suppression was also delayed in Cushing's disease, and plasma ACTH levels were less suppressed in 4 patients with Cushing's disease than in 4 patients with primary adrenocortical insufficiency at 30 (p> 0.05), 45 (p> 0.05), 60 (p <0.01) and 90 (p <0.05) min.
Generally, a patient with Cushing's disease fails to suppress urinary steroid excretion following a relatively low dose of dexamethasone, although higher doses are more effective (Liddle, 1960) . Although suppressibilities of urinary and plasma corticosteroids by dexamethasone have been widely investigated from the diagnostic standpoint, there are only a few reports as to how plasma ACTH is suppressed by the infusion of hydrocortisone in patients with Cushing's disease (Nelson et al., 1966; Sirett and Purves, 1968) . In order to know whether the relative resistence of plasma ACTH to glucocorticoid in Cushing's disease is a fundamental defect of this disease or is merely due to elevated levels of basal plasma ACTH, the response of plasma radioimmunoassayable ACTH to hydro- 
Subjects and Methods
Seven patients with Cushing's disease were investigated (Table 1) . Four of them (KS, K1, TS, SH) had been totally adrenalectomized.
Three other patients (KM, SF, SI) had clinically active Cushing's disease. Patient KM was also investigated after unilateral adrenalectomy.
Detailed endocrinological informations of these patients were already reported (Hashimoto, 1975) . Four patients with primary adrenocortical insufficiency were also examined as the control. Three of them (MO, SO, HO) had Addison's disease and another patient (TK) with adrenocortical insufficiency due to the failure of adrenal operation for primary aldosteronism. 0.5mg/kg-3.0mg/kg) was infused into an antecubital vein over 1.5 hr-2.0 hr. In patient SI, infusion had to be stopped at 45 min due to the blood coagulation in the catheter. Saline only was infused into the opposite arm through an indwelling catheter. Blood samples were collected through the catheter at 15-30 min intervals. Plasma was immediately separated and frozen, and then assayed for ACTH with a radioimmunoassay kit (Radio Chemical Center) by the extraction procedure with porous glass (Ratcliffe et al., 1971) , and for cortisol with Clark's acid fluorescent method (Clark, 1969 Hydrocortisone infusion (1.0mg/kg/1.5 hr -3 .0mg/kg/2 hr) Five patients with adrenalectomized Cushing's disease showed no significant suppression 30 min after the infusion (Table 2 , Fig. 1 ). Three (KS, TS, KM) and 2 (KI, SH) of them showed a fall of plasma ACTH below 50% level of the basal values by 60 min and 90 min, respectively. Four patients with primary adrenocortical insufficiency showed a more rapid fall of plasma ACTH. Two (SO, HO) of these patients showed a 50% suppression of plasma ACTH by 30 min, and the other 2 (MO, TK) showed a 50% suppression by 60 min. Plasma ACTH levels expressed as the percentage of basal levels were significantly less suppressed in patients with Cushing's disease than in patients with primary adrenocortical insufficiency 90 (p<0.05) and 120 min (p<0.05) after the beginning of infusion.
Hydrocortisone infusion (0.5mg/kg/1.5 hr)
In all patients with Cushing's disease, the 60 min ACTH levels remained above ( ) : total dose of hydrocortisone infused.
*Although the infusion rate was 0.5mg/kg/1.5 hr in this patient, the infusion was stopped at 45 min due to the blood coagulation of catheter. 50% of the basal levels (Table 3, Fig. 2) . In 3 of them (KS, KI, TS), plasma ACTH was suppressed to 50% level of the basal levels by 90 min. Patient SH, who showed the 50% suppression when given 1mg/kg hydrocortisone did not show the suppression with this dose of hydrocortisone, but did show the suppression one month after the treatment with 60Co irradiation (4,000 R). All of the 4 patients with primary adrenocortical insufficiency showed the 50% suppression by 60min. One (HO) showed the suppression by 30 min and 2 others (MO, TK) showed the suppression by 45 min. Plasma ACTH suppressions at 30 (p<0.05), 45 (p<O.O5), 60 (p<0.01) and 90 (p<0.05) min in Cushing's disease were significantly less than those in primary adrenocortical insufficiency.
Hydrocortisone infusion in clinically active Cushing's disease
After the infusion of 0.5 mg/kg hydrocortisone, patients SF and SI showed no suppression of plasma ACTH during the period of observation (Fig. 3) . When 1mg/kg Table 4 . Relation between the 30 min cortisol levels or mean increasing rate of cortisol till 30min and the period of 50% suppression of plasma ACTH * before pituitary irradiation ** after pituitary irradiation *** This is caluculated from the data in Fig . 1, 2 
Discussion
In order to investigate the feedback mechanism of ACTH secretion, it is one of the best methods to demonstrate how plasma ACTH is suppressed by hydrocortisone infusion. Rayyis and Bethune (1969) reported a case with Cushing's disease which showed a dramatic fall in serum ACTH following the intravenous infusion of hydrocortisone but not after the administration of dexamethasone. Meikle et al. (1974) and Perlow et al. (1974) also emphasized the advantage of using hydrocortisone rather than dexamethasone in examining the ACTH feedback mechanism. Williams et al. (1960) reported that, in patients with bilaterally adrenalectomized Cushing's disease, blood ACTH levels were not suppressed by a maintenance dose of hydrocortisone which suppressed ACTH in patients with Addison's disease. On the contrary, mean ACTH levels in patients with primary adrenocortical insufficiency were higher than in patients with Cushing's disease in our present study. The basal ACTH levels in our study were examined 14-16 hrs after the last administration of maintenance corticosteroids and, therefore, they were not the values under the administration of hydrocortisone. Sirett and Purves (1968) reported plasma ACTH levels. 24-36 hrs after the withdrawal of steroid replacement in Addison's diseases and adrenalectomized Cushing's diseases. Except for 2 very high levels from Cushing's disease patients, there was no significant difference between adrenalectomized Cushing's disease and Addison's disease. Nelson et al. (1966) reported that only 2 of 5 patients, with adrenalectomized Cushing's disease infused into with 100 mg of hydrocortisone over 4-8 hr showed partial suppression of ACTH secretion. But they did not compare the response with that in Addison's disease. Siretts and Purves (1968) reported the plasma ACTH levels 4 hr after 100mg of hydrocortisone infusion in patients with adrenalectomized Cushing's disease and Addison's disease, cortisol infusion in all cases. As they did not collect sufficient samples to determine when the 50% suppression occurred, they did not observe a significant difference between suppressibility of plasma ACTH in Cushing's disease and that in Addison's disease. Considering the episodic secretion of plasma ACTH, our 15 or 30min samplings are not sufficient enough to determine the initiation of the suppression. But it is presumed from our observations that the suppression begins between 30 and 60 min following the relatively large dose of hydrocortisone infusion in adrenalectomized Cushing's disease and it begins within 30 min in Addison's disease. The 30 min ACTH levels are higher than the basal levels in some patients with Cushing's disease. Epi-ACTH SUPPRESSION IN CUSHING'S DISEASE sodic secretion of plasma ACTH probably accounts for the high ACTH levels. Doses of hydrocortisone that failed to suppress pituitary ACTH suppression until 30min passed would not be expected to abolish episodic ACTH secretion. In patients with primary adrenocortical insufficiency given a large dose of hydrocortisone, plasma ACTH levels fell exponentially. The rapid fall of plasma ACTH levels seen in this and other reports (Besser et al., 1971 ; Krieger and Gewirtz, 1974) suggests that the negative feedback control mechanism remains almost intact in primary adrenocortical insufficiency.
The results of this experiment, the delay of ACTH suppression and the reduced suppressibility observed in Cushing's disease under the infusion of hydrocortisone may be one of the proofs of the fact that the impaired negative feedback mechanism of ACTH secretion is a fundamental defect in this disease.
